Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.

PABLO MINGUEZ GABINA; Glenn Flux; Jose Genolla; Sonia Guayambuco; Alejandro Delgado; Jose Cruz Fombellida; Katarina Sjögreen Gleisner

doi:10.1118/1.4921807

Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.

PABLO MINGUEZ GABINA, Glenn Flux, Jose Genolla, Sonia Guayambuco, Alejandro Delgado, Jose Cruz Fombellida, Katarina Sjögreen Gleisner

Medical Radiation Physics, Lund

Research output: Contribution to journal › Article › peer-review

403 Downloads (Pure)

Abstract

The aim was to investigate whole-body and red marrow absorbed doses in treatments of neuroblastoma (NB) and adult neuroendocrine tumors (NETs) with (131)I-metaiodobenzylguanidine and to propose a simple method for determining the activity to administer when dosimetric data for the individual patient are not available.

Original language	English
Pages (from-to)	3969-3978
Journal	Medical Physics
Volume	42
Issue number	7
DOIs	https://doi.org/10.1118/1.4921807
Publication status	Published - 2015

Subject classification (UKÄ)

Radiology and Medical Imaging

Access to Document

10.1118/1.4921807

3552908Accepted author manuscript, 766 KBLicence: CC BY-NC-ND

http://www.ncbi.nlm.nih.gov/pubmed/26133597?dopt=Abstract

Cite this

@article{3e3215f0eec14a36b282d9b5f9e31754,

title = "Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.",

abstract = "The aim was to investigate whole-body and red marrow absorbed doses in treatments of neuroblastoma (NB) and adult neuroendocrine tumors (NETs) with (131)I-metaiodobenzylguanidine and to propose a simple method for determining the activity to administer when dosimetric data for the individual patient are not available.",

author = "\{MINGUEZ GABINA\}, PABLO and Glenn Flux and Jose Genolla and Sonia Guayambuco and Alejandro Delgado and Fombellida, \{Jose Cruz\} and \{Sj{\"o}green Gleisner\}, Katarina",

year = "2015",

doi = "10.1118/1.4921807",

language = "English",

volume = "42",

pages = "3969--3978",

journal = "Medical Physics",

issn = "0094-2405",

publisher = "John Wiley \& Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.

AU - MINGUEZ GABINA, PABLO

AU - Flux, Glenn

AU - Genolla, Jose

AU - Guayambuco, Sonia

AU - Delgado, Alejandro

AU - Fombellida, Jose Cruz

AU - Sjögreen Gleisner, Katarina

PY - 2015

Y1 - 2015

N2 - The aim was to investigate whole-body and red marrow absorbed doses in treatments of neuroblastoma (NB) and adult neuroendocrine tumors (NETs) with (131)I-metaiodobenzylguanidine and to propose a simple method for determining the activity to administer when dosimetric data for the individual patient are not available.

AB - The aim was to investigate whole-body and red marrow absorbed doses in treatments of neuroblastoma (NB) and adult neuroendocrine tumors (NETs) with (131)I-metaiodobenzylguanidine and to propose a simple method for determining the activity to administer when dosimetric data for the individual patient are not available.

UR - https://www.scopus.com/pages/publications/84934997535

U2 - 10.1118/1.4921807

DO - 10.1118/1.4921807

M3 - Article

C2 - 26133597

SN - 0094-2405

VL - 42

SP - 3969

EP - 3978

JO - Medical Physics

JF - Medical Physics

IS - 7

ER -

Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.

Abstract

Subject classification (UKÄ)

Access to Document

Other files and links

Fingerprint

Cite this